ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').

Filter

Date Title Topic
27 Sep 2014 ESMO 2014 Press Release: Docetaxel or Pemetrexed in Addition to Cisplatin Achieve Comparable Outcomes in Non-Squamous Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Immune Checkpoint Inhibitors Provide Antitumour Activity Across Malignant Diseases Immuno-oncology
27 Sep 2014 ESMO 2014 Press Release: Anamorelin Shown to Improve Appetite and Body Mass in Patients with Cancer Anorexia-Cachexia Palliative and supportive care - Lung and other thoracic tumours
27 Sep 2014 ESMO 2014 Press Release: Cancer During Pregnancy: Chemotherapy and Radiotherapy are Safe for Babies, Studies Show Cancer in Special Situations
27 Sep 2014 ESMO 2014 Press Release: Rolapitant Reduces Nausea and Vomiting in Phase III Trial Palliative and supportive care
27 Sep 2014 ESMO 2014 Press Release: French Studies Measure Benefits of Colorectal Cancer Screening Cancer prevention - Gastrointestinal cancers
26 Sep 2014 ESMO 2014 Press Release: More Than 70% of Young Oncologists in Europe Suffer Symptoms of Burnout Bioethics, legal and economic issues
26 Sep 2014 ESMO 2014 Press Release: Discrepancies in Access to New Cancer Drugs Revealed Breast cancer - Bioethics, legal and economic issues
23 Sep 2014 ESMO Press Commentary: First international consensus guidelines published on locally advanced and metastatic breast cancer Breast cancer
19 Sep 2014 ESMO announces 15 new Designated Centres of Integrated Oncology and Palliative Care Palliative and supportive care
15 Sep 2014 MEDIA ALERT: ESMO 2014 Congress Preview
22 Aug 2014 ESMO Press Release: ESMO Honours Outstanding Oncology Professionals
25 Jul 2014 ESMO Press Release: Is Europe Putting Cancer Research at Risk? Bioethics, legal and economic issues
28 Jun 2014 World GI Press Release: Phase III Trial Shows Improved Survival with TAS-102 in Metastatic Colorectal Cancer Refractory to Standard Therapies Gastrointestinal cancers
28 Jun 2014 World GI Press Release: Phase III Trial Shows Equivalent Survival for Cetuximab or Bevacizumab with Combination Chemotherapy in Metastatic Colorectal Cancer Gastrointestinal cancers